Derek Dubay to Carcinoma, Hepatocellular
This is a "connection" page, showing publications Derek Dubay has written about Carcinoma, Hepatocellular.
Connection Strength
3.229
-
A SEER Database Analysis of the Survival Advantage of Transarterial Chemoembolization for Hepatocellular Carcinoma: An Underutilized Therapy. J Vasc Interv Radiol. 2017 Feb; 28(2):231-237.e2.
Score: 0.470
-
Successful hepatocellular carcinoma downstaging with transarterial chemoembolization followed by stereotactic radiotherapy. Liver Transpl. 2016 Apr; 22(4):547-51.
Score: 0.448
-
Adjuvant stereotactic body radiotherapy following transarterial chemoembolization in patients with non-resectable hepatocellular carcinoma tumours of = 3 cm. HPB (Oxford). 2015 Feb; 17(2):140-9.
Score: 0.401
-
Predictors of repeat transarterial chemoembolization in the treatment of hepatocellular carcinoma. HPB (Oxford). 2014 Dec; 16(12):1095-101.
Score: 0.401
-
Chemoembolization outcomes for hepatocellular carcinoma in cirrhotic patients with compromised liver function. HPB (Oxford). 2014 Jul; 16(7):648-55.
Score: 0.397
-
Computed tomography predictors of hepatocellular carcinoma tumour necrosis after chemoembolization. HPB (Oxford). 2014 Apr; 16(4):327-35.
Score: 0.374
-
Liver transplantation for advanced hepatocellular carcinoma using poor tumor differentiation on biopsy as an exclusion criterion. Ann Surg. 2011 Jan; 253(1):166-72.
Score: 0.311
-
Radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation. HPB (Oxford). 2011 Jan; 13(1):24-32.
Score: 0.308
-
Chemoembolization of Hepatocellular Carcinoma with Extrahepatic Collateral Blood Supply: Anatomic and Technical Considerations. Radiographics. 2017 May-Jun; 37(3):963-977.
Score: 0.120